Prevalence of ZnT8 antibody in relation to phenotype and SLC30A8 polymorphism in adult autoimmune diabetes. Results from the HUNT study, Norway

Autoimmunity

Volumn 46, Issue 1, 2013, Pages 74-79

  Sørgjerd, Elin Pettersen ^a   Skorpen, Frank ^b   Kvaloy, Kirsti ^a   Midthjell, Kristian ^a   Grill, Valdemar ^b,c  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Adult onset type 1 diabetes; Autoimmunity; LADA; Latent autoimmune diabetes in adult; Rs13266634; Type 1 diabetes; Young onset type 1 diabetes; ZnT8A

Indexed keywords

GLUTAMATE DECARBOXYLASE ANTIBODY; PROTEIN ANTIBODY; TUMOR ANTIGEN; TYROSINE PHOSPHATASE LIKE PROTEIN INSULINOMA ANTIGEN 2; UNCLASSIFIED DRUG; ZNT8 ANTIBODY;

ARTICLE; AUTOIMMUNE DIABETES; AUTOIMMUNE DISEASE; DIABETES MELLITUS; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LATENT AUTOIMMUNE DIABETES; MAJOR CLINICAL STUDY; NORWAY; SLC30A8 GENE;

AGE OF ONSET; CATION TRANSPORT PROTEINS; DIABETES MELLITUS, TYPE 1; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; MALE; MIDDLE AGED; NORWAY; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 8; STATISTICS, NONPARAMETRIC;

EID: 84872175139     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2012.732132     Document Type: Article

References (19)

1. Wenzlau, J. M., K. Juhl, L. Yu, et al. 2007. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc. Natl. Acad. Sci. USA 104: 17040-17045. (Pubitemid 350210987)
2. Nielsen, L. B., F. Vaziri-Sani, S. Porksen, et al. 2011. Relationship between ZnT8Ab, the SLC30A8 gene and disease progression in children with newly diagnosed type 1 diabetes. Autoimmunity 44: 616-623.
3. Wenzlau, J. M., Y. Liu, L. Yu, et al. 2008. A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes. Diabetes 57: 2693-2697.
4. Andersson, C., K. Larsson, F. Vaziri-Sani, et al. 2011. The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes. Autoimmunity 44: 394-405.
5. Kawasaki, E., K. Nakamura, G. Kuriya, et al. 2011. Differences in the humoral autoreactivity to zinc transporter 8 between childhood- And adult-onset type 1 diabetes in Japanese patients. Clin. Immunol. 138: 146-153.
6. Lampasona, V., A. Petrone, C. Tiberti, et al. 2010. Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adultonset autoimmune diabetes: Non Insulin Requiring Autoimmune Diabetes (NIRAD) 4. Diabetes Care 33: 104-108.
7. Trabucchi, A., N. I. Faccinetti, L. L. Guerra, et al. 2012. Detection and characterization of ZnT8 autoantibodies could help to screen latent autoimmune diabetes in adult-onset patients with type 2 phenotype. Autoimmunity 45: 137-142.
8. Chimienti, F., S. Devergnas, A. Favier, and M. Seve. 2004. Identification and cloning of a beta-cell-Specific zinc transporter, ZnT-8, localized into insulin secretory granules. Diabetes 53: 2330-2337. (Pubitemid 39145586)
9. Wenzlau, J. M., L.M. Frisch, T. J. Gardner, et al. 2009. Novel antigens in type 1 diabetes: The importance of ZnT8. Curr. Diab. Rep. 9: 105-112.
10. Scott, L. J., K. L. Mohlke, L. L. Bonnycastle, et al. 2007. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316: 1341-1345. (Pubitemid 46871655)
11. Staiger, H., F. Machicao, N. Stefan, et al. 2007. Polymorphisms within novel risk loci for type 2 diabetes determine betacell function. PLoS One 2: E832.
12. Pettersen, E., F. Skorpen, K. Kvaløy, K. Midthjell, and V. Grill. Genetic heterogeneity in latent autoimmune diabetes is linked to various degrees of autoimmune activity: Results from the Nord-Trondelag Health Study. Diabetes 59: 302-310.
13. Xu, K., M. Zha, X. Wu, et al. 2011. Association between rs13266634 C/T polymorphisms of solute carrier family 30 member 8 (SLC30A8) and type 2 diabetes, impaired glucose tolerance, type 1 diabetes-A meta-Analysis. Diabetes Res. Clin. Pract. 91: 195-202.
14. Achenbach, P., V. Lampasona, U. Landherr, et al. 2009. Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk. Diabetologia 52: 1881-1888.
15. Holmen, J., K. Midthjell, Ø. Krüger, et al. 2003. The Nord-Trøndelag Health Study 1995-97 (HUNT2): Objectives, contents, methods and participation. Norsk Epidemiologi 13: 19-32.
16. Sørgjerd, E. P., F. Skorpen, K. Kvaløy, K. Midthjell, and V. Grill. 2012. Time dynamics of autoantibodies are coupled to phenotypes and add to the heterogeneity of autoimmune diabetes in adults: TheHUNTstudy, Norway. Diabetologia 55: 1310-1318.
17. Vaziri-Sani, F., S. Oak, J. Radtke, et al. 2010. ZnT8 autoantibody titers in type 1 diabetes patients decline rapidly after clinical onset. Autoimmunity 43: 598-606.
18. Wenzlau, J. M.,M.Walter, T. J. Gardner, et al. 2010. Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects. J. Clin. Endocrinol. Metab. 95: 4712-4719.
19. Kawasaki, E., M. Uga, K. Nakamura, et al. 2008. Association between anti-ZnT8 autoantibody specificities and SLC30A8 Arg325Trp variant in Japanese patients with type 1 diabetes. Diabetologia 51: 2299-2302.